Literatura científica selecionada sobre o tema "Récepteurs glucocorticoïdes"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Récepteurs glucocorticoïdes".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Récepteurs glucocorticoïdes"
Riguen, M., H. Chaker, N. Dammak, S. Toumi, A. Kammoun, H. Makni, T. Boudawara, S. Yaich, K. Kammoun e M. Ben Hmida. "Apport de l’expression rénale des récepteurs aux glucocorticoïdes en immunohistochimie au cours du syndrome néphrotique idiopathique". Néphrologie & Thérapeutique 17, n.º 5 (setembro de 2021): 330. http://dx.doi.org/10.1016/j.nephro.2021.07.212.
Texto completo da fonteBen Rhouma, K., S. Schimchowitsch, M. E. Stoeckel, J. M. Felix e M. Sakly. "Implication des Récepteurs Glucocorticoïdes de Type II dans l'Action Apoptotique de l'Aldostérone sur les Thymocytes de Rat". Archives of Physiology and Biochemistry 105, n.º 2 (janeiro de 1997): 216–24. http://dx.doi.org/10.1076/apab.105.2.216.12919.
Texto completo da fonteLaulhé, M., E. Pussard, J. Perrot, P. Kamenicky, M. Lombes, S. Viengchareun e L. Martinerie. "Polymorphisme du gène du récepteur glucocorticoïde (nr3c1) et hypersensibilité aux glucocorticoïdes : mécanismes moléculaires de l’insuffisance corticotrope glucocorticoïde-induite". Annales d'Endocrinologie 82, n.º 5 (outubro de 2021): 261. http://dx.doi.org/10.1016/j.ando.2021.08.026.
Texto completo da fontePrin, L., P. Lefebvre, V. Gruart, M. Capron, L. Storme, P. Formstecher, S. Loiseau e A. Capron. "Polynucléaire éosinophile et récepteur glucocorticoïde". Revue Française d'Allergologie et d'Immunologie Clinique 30, n.º 2 (abril de 1990): 83–85. http://dx.doi.org/10.1016/s0335-7457(05)80216-3.
Texto completo da fonteBoullu, S., JG Velut, C. Oliver e M. Grino. "L'isoforme β du récepteur des glucocorticoïdes : un facteur de résistance aux glucocorticoïdes ?" médecine/sciences 14, n.º 6-7 (1998): 812. http://dx.doi.org/10.4267/10608/1147.
Texto completo da fonteRoumestan, C., C. Gougat, D. Jaffuel e M. Mathieu. "Les glucocorticoïdes et leur récepteur : mécanismes d'action et conséquences cliniques". La Revue de Médecine Interne 25, n.º 9 (setembro de 2004): 636–47. http://dx.doi.org/10.1016/j.revmed.2004.01.012.
Texto completo da fonteVilarem, MJ. "Un antituberculeux, la rifampicine : ligand et activateur du récepteur des glucocorticoïdes." médecine/sciences 14, n.º 4 (1998): 451. http://dx.doi.org/10.4267/10608/1061.
Texto completo da fonteKahn, A., e JC Dreyfus. "Le récepteur des glucocorticoïdes... et son homologie avec l'oncogène v-erb-A". médecine/sciences 2, n.º 3 (1986): 151. http://dx.doi.org/10.4267/10608/3461.
Texto completo da fonteVitellius, G., J. Bouligand, J. Fagart, F. Castinetti, A. Guiochon Mantel, B. Delemer, S. Trabado e M. Lombès. "Trois mutations originales du récepteur des glucocorticoïdes révélées par un incidentalome surrénalien". Annales d'Endocrinologie 76, n.º 4 (setembro de 2015): 320. http://dx.doi.org/10.1016/j.ando.2015.07.090.
Texto completo da fonteDalle, H., M. Garcia, T. Ledent, T. T. H. Do, M. Buyse, R. Denis, S. Luquet, B. Fève e M. Moldes. "Rôle du récepteur des glucocorticoïdes adipocytaire dans la lipodystrophie induite par la corticostérone". Annales d'Endocrinologie 77, n.º 4 (setembro de 2016): 294. http://dx.doi.org/10.1016/j.ando.2016.07.907.
Texto completo da fonteTeses / dissertações sobre o assunto "Récepteurs glucocorticoïdes"
Sablonnière, Bernard. "Organisation hétéro-oligomérique du récepteur des glucocorticoi͏̈des". Lille 1, 1988. http://www.theses.fr/1988LIL10117.
Texto completo da fonteAmbroggi, Frédéric. "Identification de la cible cellulaire des effets des glucocorticoïdes". Bordeaux 2, 2005. http://www.theses.fr/2005BOR21303.
Texto completo da fonteLustenberger, Patrick. "La chromatographie d'affinité des récepteurs des hormones stéroïdes : application à la purification du récepteur des glucocorticoi͏̈des du foie de lapin". Lille 1, 1986. http://www.theses.fr/1986LIL10137.
Texto completo da fonteBelahsen, Youness. "Purification et caractérisation du récepteur des glucocorticoïdes sous forme transformée". Lille 1, 1987. http://www.theses.fr/1987LIL10045.
Texto completo da fonteCarillo, Conesa María-Ángeles. "Le rôle des glucorticoïdes et du récepteur des glucorticoïdes dans les processus de neurodegenerescence et d'inflammation dans le Système Nerveux Central". Paris 6, 2011. http://www.theses.fr/2011PA066688.
Texto completo da fonteKootar, Scherazad. "L’importance des récepteurs aux glucocorticoïdes dans la physiopathologie de la maladie d’Alzheimer". Thesis, Université Côte d'Azur (ComUE), 2017. http://www.theses.fr/2017AZUR4015/document.
Texto completo da fonteStrong evidence shows that oligomeric forms of the amyloid-ß peptide (oAß) cause synapse dysfunction promoting loss of hippocampus-dependent memories in the early phase of Alzheimer’s disease (AD). AD is also associated with Hypothalamus-Pituitary-Adrenal (HPA) axis dysfunction which results in an increase of glucocorticoids (CORT) activating glucocorticoid receptors (GRs). We showed that subchronic GR antagonist in 4 month Tg2576 (Tg+) mice could rescue the synaptic deficit and memory impairment (Lanté et al., 2015).In this context, we studied the contribution of GRs to AD physiopathology. Dysregulated HPA axis was characterized by increased CORT levels at 4 and 6 months of age and by loss of CORT feedback inhibition in the Tg+ mice. We further crossed the Tg+ with GRlox/lox to produce GRlox/loxTg+ mice. These mice innately exhibited high CORT levels from weaning period and due to other several unforeseen reasons, we discontinued using this new mouse model. Instead, to identify the functional relationship between the GRs and oAß at synapses, we shifted to acute oAß treatment in neurons in vitro and ex-vivo hippocampus slices. In neuron cultures, GR levels increased in the post synaptic density upon acute oAß treatment. Further, treatment of oAß on ex-vivo hippocampus slices after either pharmacological blocking of GR or genetic ablation, prevented the oAβ-dependent LTP impairment. To conclude, our results with the Tg+ mice suggest that a neuroendocrine dysregulation occurs during the onset of AD pathology. Additionally, we have evidence for a functional relationship between oAß and GRs with GRs at the synapse playing an important role in acute Aß-induced synapto-toxicity
Kootar, Scherazad. "L’importance des récepteurs aux glucocorticoïdes dans la physiopathologie de la maladie d’Alzheimer". Electronic Thesis or Diss., Université Côte d'Azur (ComUE), 2017. http://www.theses.fr/2017AZUR4015.
Texto completo da fonteStrong evidence shows that oligomeric forms of the amyloid-ß peptide (oAß) cause synapse dysfunction promoting loss of hippocampus-dependent memories in the early phase of Alzheimer’s disease (AD). AD is also associated with Hypothalamus-Pituitary-Adrenal (HPA) axis dysfunction which results in an increase of glucocorticoids (CORT) activating glucocorticoid receptors (GRs). We showed that subchronic GR antagonist in 4 month Tg2576 (Tg+) mice could rescue the synaptic deficit and memory impairment (Lanté et al., 2015).In this context, we studied the contribution of GRs to AD physiopathology. Dysregulated HPA axis was characterized by increased CORT levels at 4 and 6 months of age and by loss of CORT feedback inhibition in the Tg+ mice. We further crossed the Tg+ with GRlox/lox to produce GRlox/loxTg+ mice. These mice innately exhibited high CORT levels from weaning period and due to other several unforeseen reasons, we discontinued using this new mouse model. Instead, to identify the functional relationship between the GRs and oAß at synapses, we shifted to acute oAß treatment in neurons in vitro and ex-vivo hippocampus slices. In neuron cultures, GR levels increased in the post synaptic density upon acute oAß treatment. Further, treatment of oAß on ex-vivo hippocampus slices after either pharmacological blocking of GR or genetic ablation, prevented the oAβ-dependent LTP impairment. To conclude, our results with the Tg+ mice suggest that a neuroendocrine dysregulation occurs during the onset of AD pathology. Additionally, we have evidence for a functional relationship between oAß and GRs with GRs at the synapse playing an important role in acute Aß-induced synapto-toxicity
Burollaud, Thierry. "Etude du site actif du récepteur des glucocorticoi͏̈des : modalités comparées de son interaction avec les stéroi͏̈des agonistes et antagonistes". Lille 1, 1993. http://www.theses.fr/1993LIL10091.
Texto completo da fonteFormstecher, Pierre. "Le site de liaison aux stéroi͏̈des du récepteur des glucocorticoïdes : caractérisation à l'aide de sondes moléculaires diverses". Lille 1, 1986. http://www.theses.fr/1986LIL10136.
Texto completo da fonteMuller, Caroline. "Etude du mécanisme d'action anti-glucocorticoïde des dérivés 7-hydroxylés de la déhydroépiandrostérone". Paris, CNAM, 2006. http://www.theses.fr/2006CNAM0554.
Texto completo da fonteExperiments with a confocal microscope with a COS cell line transfected with the human glucocorticoid receptor (hGR) showed that dehydroepiandrosterone (DHEA) and its 7-hydroxylated derivatives do not modify the location of the receptor and do not prevent the nuclear transfer of hGR. These steroids had no effect on the transactivation activity of hGR. Thus, these neurosteroids were inactive on this model and their genomic action through the GR could be excluded. The human 11β-hydroxysteroid dehydrogenase type 1 (h11β-HSD1) was expressed in the yeast and each of the enzyme-catalyzed reactions were analyzed. The inter-conversion of the 7-hydroxylated DHEA metabolites was demonstrated as well as the oxidoreduction of cortisol and cortisone. A competition for the binding with the h11β-HSD1 may take place between these steroids and the glucocorticoid activation process, the former triggering immunity and the latter suppressing it